Article

Targeted treatment of soft-tissue sarcoma

2022-12-05

Abstract excerpt

<title>Abstract</title> <p>Background Soft-tissue sarcoma (STS) is a heterogeneous group of sarcomas with a low incidence. The treatment of advanced disease is poor, and the mortality is high. In other types of cancer, targeted treatment has shown promising results. Therefore, we aimed to generate an overview of the clinical experiences with targeted treatments based on a pre-specified target in patients with ST...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7dbe155a-d501-5c9b-98d9-8d92d9abbfcf
DOI: 10.21203/rs.3.rs-1854280/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeted treatment of soft-tissue sarcomaDOI 10.21203/rs.3.rs-1854280/v1Read

Targetable Alterations in Adult Patients With Soft-Tissue SarcomasSemantic proximity Read

Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.Semantic proximity Read

Soft tissue sarcoma: advances in understanding and management.Semantic proximity Read

[Targeted therapies in soft-tissue and visceral sarcomas].Semantic proximity Read

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted TherapiesSemantic proximity Read

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanibSemantic proximity Read

Advances in sarcoma diagnostics and treatmentSemantic proximity Read

Making progress in a rare disease: emerging therapeutics in soft tissue sarcomasSemantic proximity Read

Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy SelectionSemantic proximity Read

NTRK1-3 Fusions in Sarcomas: Prevalence, Significance, and Clinical Implications – A Systematic ReviewSemantic proximity Read

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trialSemantic proximity Read

Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.Semantic proximity Read